Invesco DB Commodity Index Tracking Fund vs Health Care Select Sector SPDR Fund — how do they compare? Invesco DB Commodity Index Tracking Fund trades at $32.8 (market cap $1.93B), while Health Care Select Sector SPDR Fund trades at $168.16 (market cap $43.11B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 22.3× Invesco DB Commodity Index Tracking Fund's market cap, and Invesco DB Commodity Index Tracking Fund is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco DB Commodity Index Tracking Fund for 61 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| DBC | XLV | |
|---|---|---|
Market Cap | $1.93B | $43.11B |
Volume | 569,977 | 8,870,090 |
Sector | Commodities - Metals/Agriculture | — |
52-Week High | $33.68 | $175.68 |
52-Week Low | $22.07 | $141.95 |
Typical Hold Time | 61 Days | 100 Days |
Signals from Pluang's Aura AI — not financial advice
DBC trades at $32.51, down 0.55% on the day, with a bullish technical signal from moving averages. The company reported $82.59M in revenue and $22.38M net income for 2024, showing improved profitability from 2023's loss. Cash flow from operations was strong at $431.54M, contributing to a healthy balance sheet with $1.28B in shareholder equity and minimal debt.
The outlook appears favorable with positive earnings momentum and robust operational cash flow. Key risks include revenue volatility, as seen in historical fluctuations, and dependence on commodity market conditions. Analyst sentiment is constructive given the bullish technical indicators and improved financial performance.
XLV trades at $168.81, up 1.03% with a bullish technical signal from moving averages. The healthcare ETF shows strength with 61 diversified holdings and a low 0.08% expense ratio. Recent news highlights its defensive characteristics during market volatility and potential benefits from rising interest rates. Technical indicators show support at $168 with resistance at $170, while oscillators remain neutral.
XLV offers defensive exposure to healthcare with cost efficiency, though concentration in S&P 500 stocks limits global diversification. Political uncertainty and sector-specific risks like FDA approvals present challenges, but the ETF's broad diversification and historical performance during rate hikes support a constructive outlook for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
DBC is a diversified commodity ETF that tracks the DBIQ Optimum Yield Diversified Commodity Index. It invests in futures contracts for 14 heavily traded commodities, including crude oil, gold, and corn, while optimizing for yield and roll costs.
Read more on DBC →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →